000 | 01349 a2200421 4500 | ||
---|---|---|---|
005 | 20250513191637.0 | ||
264 | 0 | _c19991119 | |
008 | 199911s 0 0 eng d | ||
022 | _a0143-5221 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDownie, P F | |
245 | 0 | 0 |
_aAssessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. _h[electronic resource] |
260 |
_bClinical science (London, England : 1979) _cSep 1999 |
||
300 |
_a255-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aBlood Preservation |
650 | 0 | 4 | _aBlood Specimen Collection |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVentricular Dysfunction, Left _xblood |
700 | 1 | _aTalwar, S | |
700 | 1 | _aSquire, I B | |
700 | 1 | _aDavies, J E | |
700 | 1 | _aBarnett, D B | |
700 | 1 | _aNg, L L | |
773 | 0 |
_tClinical science (London, England : 1979) _gvol. 97 _gno. 3 _gp. 255-8 |
|
999 |
_c10421617 _d10421617 |